Necrotic Enteritis Drug Market, Global Outlook and Forecast 2022-2028

April 2022 | 61 pages | ID: N95464BAE622EN
Market Monitor Global

Abstracts

Necrotic enteritis also called as necrotizing enterocolitis is inflammatory bowel disease found prematurely born infants.

This report contains market size and forecasts of Necrotic Enteritis Drug in Global, including the following market information:

Global Necrotic Enteritis Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Necrotic Enteritis Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Inter Alpha Inhibitor Proteins Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Necrotic Enteritis Drug include Prometic Life Sciences, BioGaia Probiotics, Fresenius, Teva, Bayer, Alcon and GlaxoSmithKline, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Necrotic Enteritis Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Necrotic Enteritis Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Necrotic Enteritis Drug Market Segment Percentages, by Type, 2021 (%)

• Inter Alpha Inhibitor Proteins
• Antibiotics

Global Necrotic Enteritis Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Necrotic Enteritis Drug Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Global Necrotic Enteritis Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Necrotic Enteritis Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Necrotic Enteritis Drug revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Necrotic Enteritis Drug revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Prometic Life Sciences
• BioGaia Probiotics
• Fresenius
• Teva
• Bayer
• Alcon
• GlaxoSmithKline

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Necrotic Enteritis Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Necrotic Enteritis Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL NECROTIC ENTERITIS DRUG OVERALL MARKET SIZE

2.1 Global Necrotic Enteritis Drug Market Size: 2021 VS 2028
2.2 Global Necrotic Enteritis Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Necrotic Enteritis Drug Players in Global Market
3.2 Top Global Necrotic Enteritis Drug Companies Ranked by Revenue
3.3 Global Necrotic Enteritis Drug Revenue by Companies
3.4 Top 3 and Top 5 Necrotic Enteritis Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Necrotic Enteritis Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Necrotic Enteritis Drug Players in Global Market
  3.6.1 List of Global Tier 1 Necrotic Enteritis Drug Companies
  3.6.2 List of Global Tier 2 and Tier 3 Necrotic Enteritis Drug Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Necrotic Enteritis Drug Market Size Markets, 2021 & 2028
  4.1.2 Inter Alpha Inhibitor Proteins
  4.1.3 Antibiotics
4.2 By Type - Global Necrotic Enteritis Drug Revenue & Forecasts
  4.2.1 By Type - Global Necrotic Enteritis Drug Revenue, 2017-2022
  4.2.2 By Type - Global Necrotic Enteritis Drug Revenue, 2023-2028
  4.2.3 By Type - Global Necrotic Enteritis Drug Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Necrotic Enteritis Drug Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacy
  5.1.3 Retail Pharmacy
  5.1.4 Online Pharmacy
5.2 By Application - Global Necrotic Enteritis Drug Revenue & Forecasts
  5.2.1 By Application - Global Necrotic Enteritis Drug Revenue, 2017-2022
  5.2.2 By Application - Global Necrotic Enteritis Drug Revenue, 2023-2028
  5.2.3 By Application - Global Necrotic Enteritis Drug Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Necrotic Enteritis Drug Market Size, 2021 & 2028
6.2 By Region - Global Necrotic Enteritis Drug Revenue & Forecasts
  6.2.1 By Region - Global Necrotic Enteritis Drug Revenue, 2017-2022
  6.2.2 By Region - Global Necrotic Enteritis Drug Revenue, 2023-2028
  6.2.3 By Region - Global Necrotic Enteritis Drug Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Necrotic Enteritis Drug Revenue, 2017-2028
  6.3.2 US Necrotic Enteritis Drug Market Size, 2017-2028
  6.3.3 Canada Necrotic Enteritis Drug Market Size, 2017-2028
  6.3.4 Mexico Necrotic Enteritis Drug Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Necrotic Enteritis Drug Revenue, 2017-2028
  6.4.2 Germany Necrotic Enteritis Drug Market Size, 2017-2028
  6.4.3 France Necrotic Enteritis Drug Market Size, 2017-2028
  6.4.4 U.K. Necrotic Enteritis Drug Market Size, 2017-2028
  6.4.5 Italy Necrotic Enteritis Drug Market Size, 2017-2028
  6.4.6 Russia Necrotic Enteritis Drug Market Size, 2017-2028
  6.4.7 Nordic Countries Necrotic Enteritis Drug Market Size, 2017-2028
  6.4.8 Benelux Necrotic Enteritis Drug Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Necrotic Enteritis Drug Revenue, 2017-2028
  6.5.2 China Necrotic Enteritis Drug Market Size, 2017-2028
  6.5.3 Japan Necrotic Enteritis Drug Market Size, 2017-2028
  6.5.4 South Korea Necrotic Enteritis Drug Market Size, 2017-2028
  6.5.5 Southeast Asia Necrotic Enteritis Drug Market Size, 2017-2028
  6.5.6 India Necrotic Enteritis Drug Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Necrotic Enteritis Drug Revenue, 2017-2028
  6.6.2 Brazil Necrotic Enteritis Drug Market Size, 2017-2028
  6.6.3 Argentina Necrotic Enteritis Drug Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Necrotic Enteritis Drug Revenue, 2017-2028
  6.7.2 Turkey Necrotic Enteritis Drug Market Size, 2017-2028
  6.7.3 Israel Necrotic Enteritis Drug Market Size, 2017-2028
  6.7.4 Saudi Arabia Necrotic Enteritis Drug Market Size, 2017-2028
  6.7.5 UAE Necrotic Enteritis Drug Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Prometic Life Sciences
  7.1.1 Prometic Life Sciences Corporate Summary
  7.1.2 Prometic Life Sciences Business Overview
  7.1.3 Prometic Life Sciences Necrotic Enteritis Drug Major Product Offerings
  7.1.4 Prometic Life Sciences Necrotic Enteritis Drug Revenue in Global Market (2017-2022)
  7.1.5 Prometic Life Sciences Key News
7.2 BioGaia Probiotics
  7.2.1 BioGaia Probiotics Corporate Summary
  7.2.2 BioGaia Probiotics Business Overview
  7.2.3 BioGaia Probiotics Necrotic Enteritis Drug Major Product Offerings
  7.2.4 BioGaia Probiotics Necrotic Enteritis Drug Revenue in Global Market (2017-2022)
  7.2.5 BioGaia Probiotics Key News
7.3 Fresenius
  7.3.1 Fresenius Corporate Summary
  7.3.2 Fresenius Business Overview
  7.3.3 Fresenius Necrotic Enteritis Drug Major Product Offerings
  7.3.4 Fresenius Necrotic Enteritis Drug Revenue in Global Market (2017-2022)
  7.3.5 Fresenius Key News
7.4 Teva
  7.4.1 Teva Corporate Summary
  7.4.2 Teva Business Overview
  7.4.3 Teva Necrotic Enteritis Drug Major Product Offerings
  7.4.4 Teva Necrotic Enteritis Drug Revenue in Global Market (2017-2022)
  7.4.5 Teva Key News
7.5 Bayer
  7.5.1 Bayer Corporate Summary
  7.5.2 Bayer Business Overview
  7.5.3 Bayer Necrotic Enteritis Drug Major Product Offerings
  7.5.4 Bayer Necrotic Enteritis Drug Revenue in Global Market (2017-2022)
  7.5.5 Bayer Key News
7.6 Alcon
  7.6.1 Alcon Corporate Summary
  7.6.2 Alcon Business Overview
  7.6.3 Alcon Necrotic Enteritis Drug Major Product Offerings
  7.6.4 Alcon Necrotic Enteritis Drug Revenue in Global Market (2017-2022)
  7.6.5 Alcon Key News
7.7 GlaxoSmithKline
  7.7.1 GlaxoSmithKline Corporate Summary
  7.7.2 GlaxoSmithKline Business Overview
  7.7.3 GlaxoSmithKline Necrotic Enteritis Drug Major Product Offerings
  7.7.4 GlaxoSmithKline Necrotic Enteritis Drug Revenue in Global Market (2017-2022)
  7.7.5 GlaxoSmithKline Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Necrotic Enteritis Drug Market Opportunities & Trends in Global Market
Table 2. Necrotic Enteritis Drug Market Drivers in Global Market
Table 3. Necrotic Enteritis Drug Market Restraints in Global Market
Table 4. Key Players of Necrotic Enteritis Drug in Global Market
Table 5. Top Necrotic Enteritis Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Necrotic Enteritis Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Necrotic Enteritis Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Necrotic Enteritis Drug Product Type
Table 9. List of Global Tier 1 Necrotic Enteritis Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Necrotic Enteritis Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Necrotic Enteritis Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Necrotic Enteritis Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Necrotic Enteritis Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Necrotic Enteritis Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Necrotic Enteritis Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Necrotic Enteritis Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Necrotic Enteritis Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Necrotic Enteritis Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Necrotic Enteritis Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Necrotic Enteritis Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Necrotic Enteritis Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Necrotic Enteritis Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Necrotic Enteritis Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Necrotic Enteritis Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Necrotic Enteritis Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Necrotic Enteritis Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Necrotic Enteritis Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Necrotic Enteritis Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Necrotic Enteritis Drug Revenue, (US$, Mn), 2023-2028
Table 30. Prometic Life Sciences Corporate Summary
Table 31. Prometic Life Sciences Necrotic Enteritis Drug Product Offerings
Table 32. Prometic Life Sciences Necrotic Enteritis Drug Revenue (US$, Mn), (2017-2022)
Table 33. BioGaia Probiotics Corporate Summary
Table 34. BioGaia Probiotics Necrotic Enteritis Drug Product Offerings
Table 35. BioGaia Probiotics Necrotic Enteritis Drug Revenue (US$, Mn), (2017-2022)
Table 36. Fresenius Corporate Summary
Table 37. Fresenius Necrotic Enteritis Drug Product Offerings
Table 38. Fresenius Necrotic Enteritis Drug Revenue (US$, Mn), (2017-2022)
Table 39. Teva Corporate Summary
Table 40. Teva Necrotic Enteritis Drug Product Offerings
Table 41. Teva Necrotic Enteritis Drug Revenue (US$, Mn), (2017-2022)
Table 42. Bayer Corporate Summary
Table 43. Bayer Necrotic Enteritis Drug Product Offerings
Table 44. Bayer Necrotic Enteritis Drug Revenue (US$, Mn), (2017-2022)
Table 45. Alcon Corporate Summary
Table 46. Alcon Necrotic Enteritis Drug Product Offerings
Table 47. Alcon Necrotic Enteritis Drug Revenue (US$, Mn), (2017-2022)
Table 48. GlaxoSmithKline Corporate Summary
Table 49. GlaxoSmithKline Necrotic Enteritis Drug Product Offerings
Table 50. GlaxoSmithKline Necrotic Enteritis Drug Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Necrotic Enteritis Drug Segment by Type in 2021
Figure 2. Necrotic Enteritis Drug Segment by Application in 2021
Figure 3. Global Necrotic Enteritis Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Necrotic Enteritis Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Necrotic Enteritis Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Necrotic Enteritis Drug Revenue in 2021
Figure 8. By Type - Global Necrotic Enteritis Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Necrotic Enteritis Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Necrotic Enteritis Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Necrotic Enteritis Drug Revenue Market Share, 2017-2028
Figure 12. US Necrotic Enteritis Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Necrotic Enteritis Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Necrotic Enteritis Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Necrotic Enteritis Drug Revenue Market Share, 2017-2028
Figure 16. Germany Necrotic Enteritis Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Necrotic Enteritis Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Necrotic Enteritis Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Necrotic Enteritis Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Necrotic Enteritis Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Necrotic Enteritis Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Necrotic Enteritis Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Necrotic Enteritis Drug Revenue Market Share, 2017-2028
Figure 24. China Necrotic Enteritis Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Necrotic Enteritis Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Necrotic Enteritis Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Necrotic Enteritis Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Necrotic Enteritis Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Necrotic Enteritis Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Necrotic Enteritis Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Necrotic Enteritis Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Necrotic Enteritis Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Necrotic Enteritis Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Necrotic Enteritis Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Necrotic Enteritis Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Necrotic Enteritis Drug Revenue, (US$, Mn), 2017-2028
Figure 37. Prometic Life Sciences Necrotic Enteritis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. BioGaia Probiotics Necrotic Enteritis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Fresenius Necrotic Enteritis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Teva Necrotic Enteritis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Bayer Necrotic Enteritis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Alcon Necrotic Enteritis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. GlaxoSmithKline Necrotic Enteritis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)